Iceland· IS-EU/1/14/898/001-003

Anoro Ellipta

A vilanterol und umeclidinium bromid product containing vilanterolum inn trífenatat,umeclidinii bromidum inn, registered in Iceland by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 11 of our 19 countries.

ATC R03AL03

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedAnoro ElliptaATCR03AL03REGISTER NO.IS-EU/1/14/898/001-003PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Vilanterol und umeclidinium bromid is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AL03 (vilanterol und umeclidinium bromid), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 7 of them publish a price we can compare per daily dose

Vilanterol und umeclidinium bromid · ATC R03AL03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Vilanterolum INN trífenatat,Umeclidinii bromidum INN
Manufacturer
GlaxoSmithKline Trading Services Limited
Country
Iceland (IS)
ATC code
R03AL03
ATC class
Vilanterol und Umeclidinium bromid
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 1

1 priced
  • ean
    504120
    30 skammtar x1 innö.t
    ISK 9076

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8f82444a-7483-490d-aa5b-1cdf4e623c95
GET /v1/drugs/8f82444a-7483-490d-aa5b-1cdf4e623c95?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Innöndunarduft, afmældir skammtar",
  "source": "lyfjastofnun",
  "atc_raw": "R03AL03",
  "marketed": true,
  "strength": "55 míkróg/22 míkróg",
  "ma_number": "EU/1/14/898/001-003",
  "substance": "Vilanterolum INN trífenatat,Umeclidinii bromidum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "41767"
}

See everything about vilanterol und umeclidinium bromid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.